Mastocytosis: current concepts in diagnosis and treatment

Escribano, L.; Akin, C.; Castells, M.; Orfao, A.; Metcalfe, D.
December 2002
Annals of Hematology;Dec2002, Vol. 81 Issue 12, p677
Academic Journal
Mastocytosis consists of a group of disorders characterized by a pathologic increase in mast cells in tissues including skin, bone marrow, liver, spleen, and lymph nodes. Mastocytosis is a rare disease. Because of this, general practitioners have limited exposure to its clinical manifestations, diagnosis, classification, and management. Diagnosis of mastocytosis is suspected on clinical grounds and is established by histopathologic examination of involved tissues such as skin and bone marrow. The most common clinical sign of mastocytosis is the presence of typical skin lesions of urticaria pigmentosa. Most patients experience symptoms related to mast cell mediator release, and prevention of the effects of these mediators on tissues constitutes the major therapeutic goal in the management of mastocytosis. Despite recent advances in knowledge about the pathophysiology, diagnosis, and classification of mastocytosis, a curative treatment for mastocytosis does not now exist. Management of patients within all categories of mastocytosis includes: (1) a careful counseling of patients (parents in pediatric cases) and care providers, (2) avoidance of factors triggering acute mediator release, (3) treatment of acute mast cell mediator release, (4) treatment of chronic mast cell mediator release, and if indicated (5) an attempt to treat organ infiltration by mast cells. The goal of this manuscript is to provide an overview of the mediators produced and released by mast cells, the diagnostic criteria for the different variants of mastocytosis, and the treatment options currently available.


Related Articles

  • Smouldering systemic mastocytosis with lymph node involvement mimicking malignant lymphoma. Xu, Z.; Jamison, B.; Bence-Bruckler, I. // Annals of Hematology;Sep2014, Vol. 93 Issue 9, p1603 

    The article presents a case study of a 65-year-old man with enlarged abdominal lymphadenopathy who was diagnosed with smouldering systemic mastocytosis (SM). Topics include a description of SM, the World Health Organization (WHO) SM diagnostic criteria, and the patient's computed tomography (CT)...

  • Mastocytosis: Classification, Diagnosis, and Clinical Presentation. Castells, Mariana C. // Allergy & Asthma Proceedings;Jan/Feb2004, Vol. 25 Issue 1, p33 

    Mastocytosis comprises several diseases characterized by an abnormal increase in tissue mast cells. Cutaneous mastocytosis (CM) is the most common form of mastocytosis, affects predominantly children, and presents as a mast cell hyperplasia limited to the skin. Systemic mastocytosis (SM)...

  • The Liver, Spleen, and Lymph Nodes in Mastocytosis. Metcalfe, Dean D. // Journal of Investigative Dermatology;Mar1991, Vol. 96 Issue 3, p45S 

    In systemic mastocytosis the liver, spleen, and lymph nodes may be infiltrated by mast cells, with patterns of infiltration specific for each tissue. This may result in hepatosplenomegaly and enlarged lymph nodes. Extensive involvement with mast cells may also be associated with organ...

  • Systemic mastocytosis. Thanh Bihn Nguyen; Belisle // Canadian Association of Radiologists Journal;Aug99, Vol. 50 Issue 4, p272 

    Presents a diagnosis for the medical case published in the September 1999 issue of the periodical `Canadian Association of Radiologists Journal.' Symptoms include abdominal distension, weight loss and anorexia; Presence of mild leukocytosis; Description of the disease systemic mastocytosis.

  • Occipital anaplastic oligodendroglioma with multiple organ metastases after a short clinical course: a case report and literature review. Gang Li; Zhiguo Zhang; Jianghong Zhang; Tianbo Jin; Hongjuan Liang; Li Gong; Guangbin Cui; Haixia Yang; Shiming He; Yongsheng Zhang; Guodong Gao // Diagnostic Pathology;2014, Vol. 9 Issue 1, p1 

    Background It is generally believed that malignant gliomas never metastasize outside the central nervous system (CNS). However, the notion that oligodendrogliomas (OGDs) cells cannot spread outside CNS is being challenged. Methods We described in detail the clinical story of one patient with...

  • Systemic mastocytosis presenting with a prominent B lymphocyte proliferation in the bone marrow and extensive fibrosis of the spleen. Neşe, Nalan; Çağirga, Seçkin; Ertan, Yešim; Sönmez, Ayhan; Soydan, Saliha; Hekimgil, Mine // Disease Markers;2007, Vol. 23 Issue 3, p167 

    Systemic mastocytosis is a disease characterized by multifocal mast cell proliferation in the bone marrow or other extracutaneous organs. Because of loosely scattered and hypo-/agranular mast cells, the diagnosis is sometimes very difficult. In the bone marrow, mast cell infiltration may be...

  • Advanced imaging of skeletal manifestations of systemic mastocytosis. Fritz, J.; Fishman, E.; Carrino, J.; Horger, M. // Skeletal Radiology;Aug2012, Vol. 41 Issue 8, p887 

    Systemic mastocytosis comprises a group of clonal disorders of the mast cell that most commonly involves the skeletal system. Imaging can be helpful in the detection and characterization of the osseous manifestations of this disease. While radiography and bone scans are frequently used for this...

  • Mast cell repopulation of the peritoneal cavity: contribution of mast cell progenitors versus bone marrow derived committed mast cell precursors. Jamur, Maria Célia; Moreno, Andréa N.; Mello, Luciana F. C.; Souza, Júnior, Devandir A.; Campos, Maria Rita C.; Pastor, Maria Verônica D.; Grodzki, Ana Cristina G.; Silva, Deise C.; Oliver, Constance // BMC Immunology;2010, Vol. 11, p32 

    Background: Mast cells have recently gained new importance as immunoregulatory cells that are involved in numerous pathological processes. One result of these processes is an increase in mast cell numbers at peripheral sites. This study was undertaken to determine the mast cell response in the...

  • An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL). Horny, H. -P.; Sotlar, K.; Stellmacher, F.; Valent, P.; Grabbe, J. // Journal of Clinical Pathology;Mar2006, Vol. 59 Issue 3, p264 

    Aims: Whereas focal accumulations of reactive lymphocytes around mast cell (MC) infiltrates are often seen in indolent systemic mastocytosis (ISM) involving the bone marrow, an association of systemic mastocytosis (SM) with malignant lymphoma/lymphatic leukaemia is very rare. This report...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics